Kornit Digital CTO sells 97,066 shares under plan
Two fully vested options were listed: one for 3,279 shares expiring August 8, 2028, and one for 17,000 shares expiring January 31, 2032.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Kornit Digital Ltd.'s Chief Technology Officer, Yaaqov Mann, sold 97,066 ordinary shares on October 2 and October 5, 2026, under a Rule 10b5-1 plan. Reported weighted-average sale prices were $17.27 per share on October 2 and $17.66 per share on October 5.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 97,066 shares
Net Sell
12 txns
Insider
Mann Yaaqov
Role
Chief Technology Officer
Sold
97,066 shs ($1.69M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F1, F3 | 598 | $17.66 | $11K |
| Sale | Ordinary Shares F1, F4 | 477 | $17.66 | $8K |
| Sale | Ordinary Shares F1, F5 | 33,131 | $17.66 | $585K |
| Sale | Ordinary Shares F1, F6 | 3,876 | $17.66 | $68K |
| Sale | Ordinary Shares F1, F7 | 1,876 | $17.66 | $33K |
| Sale | Ordinary Shares F1 | 25,680 | $17.27 | $443K |
| Sale | Ordinary Shares F1, F2 | 4,120 | $17.27 | $71K |
| Sale | Ordinary Shares F1, F3 | 7,766 | $17.27 | $134K |
| Sale | Ordinary Shares F1, F4 | 4,286 | $17.27 | $74K |
| Sale | Ordinary Shares F1, F5 | 15,256 | $17.27 | $263K |
| holding | Stock Option (right to buy) F8, F9 | -- | -- | -- |
| holding | Stock Option (right to buy) F8, F9 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 7,569 shares (Direct);
Stock Option (right to buy) — 20,279 contracts (Direct)
Footnotes (9)
- F1. The price reported represents a weighted average price. The Reporting Person undertakes to provide to the SEC staff, upon request, full information regarding the number of shares and prices at which the transactions were effected.
- F2. The ordinary shares reported in this row consist of shares that were issued upon settlement of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person on August 10, 2022 and that have fully vested and settled for underlying ordinary shares.
- F3. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 9, 2023 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the original 9,559 RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the original 9,559 RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row (which reflects a reduced number relative to the originally granted amount due to sales of underlying shares to date) will be fully vested and settled by the four-year anniversary of that grant date (March 9, 2027).
- F4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 14, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the original 7,621 RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the original 7,621 RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row (which reflects a reduced number relative to the originally granted amount due to sales of underlying shares to date) will be fully vested and settled by the four-year anniversary of that grant date (March 14, 2028).
- F5. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on July 11, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the original 96,774 RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the original 96,774 RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row (which reflects a reduced number relative to the originally granted amount due to sales of underlying shares to date) will be fully vested and settled by the four-year anniversary of that grant date (July 11, 2028).
- F6. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on July 11, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the original 7,752 RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the original 7,752 RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row (which reflects a reduced number relative to the originally granted amount due to sales of underlying shares to date) will be fully vested and settled by the four-year anniversary of that grant date (July 11, 2028).
- F7. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 13, 2025 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the original 9,445 RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the original 9,445 RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row (which reflects a reduced number relative to the originally granted amount due to sales of underlying shares to date) will be fully vested and settled by the four-year anniversary of that grant date (March 13, 2029).
- F8. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F9. The options to purchase ordinary shares reported in this row are fully vested and became exercisable prior to the date of this report.
Key Figures
Shares sold: 97,066 ordinary shares
Weighted-average sale price: $17.27 per share
Weighted-average sale price: $17.66 per share
+4 more
7 metrics
Shares sold
97,066 ordinary shares
Sales on October 2 and October 5, 2026
Weighted-average sale price
$17.27 per share
October 2, 2026
Weighted-average sale price
$17.66 per share
October 5, 2026
Option underlying shares
3,279 ordinary shares
Fully vested option expiring August 8, 2028
Option exercise price
$18.80 per share
Option covering 3,279 ordinary shares and expiring August 8, 2028
Option underlying shares
17,000 ordinary shares
Fully vested option expiring January 31, 2032
Option exercise price
$105.06 per share
Option covering 17,000 ordinary shares and expiring January 31, 2032
Key Terms
weighted average price, restricted share units, fully vested, Stock Option (right to buy)
4 terms
weighted average price financial
"The price reported represents a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
fully vested financial
"The options to purchase ordinary shares reported in this row are fully vested"
Stock Option (right to buy) technical
"Stock Option (right to buy)"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did KRNT's Chief Technology Officer hold?
Yaaqov Mann's reported holdings on October 2, 2026, included fully vested options for 3,279 ordinary shares at an $18.80 exercise price, expiring August 8, 2028, and 17,000 ordinary shares at a $105.06 exercise price, expiring January 31, 2032.
AI-generated analysis. How Rhea-AI works. Not financial advice.
